Skip to main content
. 2015 Mar 30;10(3):e0121739. doi: 10.1371/journal.pone.0121739

Fig 1. Receiver operating characteristic analysis using serum caspase-cleaved cytokeratin (CCCK)-18 levels as a predictor of mortality at 30 days.

Fig 1